Futura Medical (LON:FUM) Issues Quarterly Earnings Results

Futura Medical (LON:FUM) announced its quarterly earnings results on Tuesday. The company reported GBX (0.20) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Futura Medical had a negative return on equity of 310.00% and a negative net margin of 534.62%.

Futura Medical Stock Performance

Shares of LON FUM traded down GBX 0.05 during trading hours on Thursday, hitting GBX 0.28. The company’s stock had a trading volume of 18,645,404 shares, compared to its average volume of 9,214,374. Futura Medical has a 12 month low of GBX 0.20 and a 12 month high of GBX 10.45. The stock has a market cap of £1.62 million, a price-to-earnings ratio of -0.10 and a beta of 0.02. The business has a 50-day simple moving average of GBX 0.42 and a 200-day simple moving average of GBX 0.78.

Futura Medical Company Profile

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.